CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
| Active as of 2023-05-05 |
{
"resourceType" : "ValueSet",
"id" : "med-prior-exposure-vs",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>10473</td><td>thiotepa</td></tr><tr><td>1156487</td><td>thiotepa Injectable Product</td></tr><tr><td>1185673</td><td>Mylotarg Injectable Product</td></tr><tr><td>1294580</td><td>gemtuzumab ozogamicin</td></tr><tr><td>1294581</td><td>gemtuzumab ozogamicin 1 MG/ML</td></tr><tr><td>1294582</td><td>gemtuzumab ozogamicin Injectable Product</td></tr><tr><td>1294583</td><td>gemtuzumab ozogamicin Injectable Solution</td></tr><tr><td>1294584</td><td>gemtuzumab ozogamicin 1 MG/ML Injectable Solution</td></tr><tr><td>1366537</td><td>Tepadina</td></tr><tr><td>1597258</td><td>blinatumomab</td></tr><tr><td>1597260</td><td>blinatumomab Injectable Product</td></tr><tr><td>1597262</td><td>blinatumomab 0.035 MG Injection</td></tr><tr><td>1597263</td><td>Blincyto</td></tr><tr><td>1597266</td><td>Blincyto Injectable Product</td></tr><tr><td>1597267</td><td>blinatumomab 0.035 MG Injection [Blincyto]</td></tr><tr><td>1651249</td><td>blinatumomab 0.035 MG</td></tr><tr><td>1651250</td><td>blinatumomab Injection</td></tr><tr><td>1651252</td><td>blinatumomab 0.035 MG [Blincyto]</td></tr><tr><td>1651253</td><td>blinatumomab Injection [Blincyto]</td></tr><tr><td>1660002</td><td>thiotepa 100 MG</td></tr><tr><td>1660003</td><td>thiotepa Injection</td></tr><tr><td>1660004</td><td>thiotepa 100 MG Injection</td></tr><tr><td>1660008</td><td>thiotepa 15 MG</td></tr><tr><td>1660009</td><td>thiotepa 15 MG Injection</td></tr><tr><td>1919206</td><td>thiotepa 100 MG [Tepadina]</td></tr><tr><td>1919207</td><td>thiotepa Injection [Tepadina]</td></tr><tr><td>1919208</td><td>Tepadina Injectable Product</td></tr><tr><td>1919209</td><td>thiotepa 100 MG Injection [Tepadina]</td></tr><tr><td>1919210</td><td>thiotepa 15 MG [Tepadina]</td></tr><tr><td>1919211</td><td>thiotepa 15 MG Injection [Tepadina]</td></tr><tr><td>1942950</td><td>inotuzumab ozogamicin</td></tr><tr><td>1942951</td><td>inotuzumab ozogamicin 0.9 MG</td></tr><tr><td>1942952</td><td>inotuzumab ozogamicin Injectable Product</td></tr><tr><td>1942953</td><td>inotuzumab ozogamicin Injection</td></tr><tr><td>1942954</td><td>inotuzumab ozogamicin 0.9 MG Injection</td></tr><tr><td>1942955</td><td>Besponsa</td></tr><tr><td>1942956</td><td>inotuzumab ozogamicin 0.9 MG [Besponsa]</td></tr><tr><td>1942957</td><td>inotuzumab ozogamicin Injection [Besponsa]</td></tr><tr><td>1942958</td><td>Besponsa Injectable Product</td></tr><tr><td>1942959</td><td>inotuzumab ozogamicin 0.9 MG Injection [Besponsa]</td></tr><tr><td>1944699</td><td>gemtuzumab ozogamicin 4.5 MG</td></tr><tr><td>1944700</td><td>gemtuzumab ozogamicin Injection</td></tr><tr><td>1944701</td><td>gemtuzumab ozogamicin 4.5 MG Injection</td></tr><tr><td>1944702</td><td>gemtuzumab ozogamicin 4.5 MG [Mylotarg]</td></tr><tr><td>1944703</td><td>gemtuzumab ozogamicin Injection [Mylotarg]</td></tr><tr><td>1944704</td><td>gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg]</td></tr><tr><td>2054068</td><td>mogamulizumab</td></tr><tr><td>2054077</td><td>mogamulizumab-kpkc</td></tr><tr><td>2054078</td><td>mogamulizumab-kpkc 4 MG/ML</td></tr><tr><td>2054079</td><td>mogamulizumab Injectable Product</td></tr><tr><td>2054080</td><td>mogamulizumab Injection</td></tr><tr><td>2054081</td><td>5 ML mogamulizumab-kpkc 4 MG/ML Injection</td></tr><tr><td>2054082</td><td>Poteligeo</td></tr><tr><td>2054083</td><td>mogamulizumab-kpkc 4 MG/ML [Poteligeo]</td></tr><tr><td>2054084</td><td>mogamulizumab Injection [Poteligeo]</td></tr><tr><td>2054085</td><td>Poteligeo Injectable Product</td></tr><tr><td>2054086</td><td>5 ML mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo]</td></tr><tr><td>261585</td><td>Mylotarg</td></tr></table></li></ul></div>"
},
"url" : "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-prior-exposure-vs",
"version" : "0.1.6",
"name" : "RxNormPriorExposureVS",
"title" : "RxNorm - Prior Exposure: Potential Study Eligibility",
"status" : "active",
"experimental" : true,
"date" : "2023-05-05T10:50:04-05:00",
"publisher" : "The Medical College of Wisconsin, Inc. and the National Marrow Donor Program",
"contact" : [
{
"name" : "The Medical College of Wisconsin, Inc. and the National Marrow Donor Program",
"telecom" : [
{
"system" : "url",
"value" : "http://www.cibmtr.org"
}
]
},
{
"name" : "Bob Milius",
"telecom" : [
{
"system" : "email",
"value" : "bmilius@nmdp.org"
}
]
}
],
"description" : "Prior Exposure: Potential Study Eligibility",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "10473",
"display" : "thiotepa"
},
{
"code" : "1156487",
"display" : "thiotepa Injectable Product"
},
{
"code" : "1185673",
"display" : "Mylotarg Injectable Product"
},
{
"code" : "1294580",
"display" : "gemtuzumab ozogamicin"
},
{
"code" : "1294581",
"display" : "gemtuzumab ozogamicin 1 MG/ML"
},
{
"code" : "1294582",
"display" : "gemtuzumab ozogamicin Injectable Product"
},
{
"code" : "1294583",
"display" : "gemtuzumab ozogamicin Injectable Solution"
},
{
"code" : "1294584",
"display" : "gemtuzumab ozogamicin 1 MG/ML Injectable Solution"
},
{
"code" : "1366537",
"display" : "Tepadina"
},
{
"code" : "1597258",
"display" : "blinatumomab"
},
{
"code" : "1597260",
"display" : "blinatumomab Injectable Product"
},
{
"code" : "1597262",
"display" : "blinatumomab 0.035 MG Injection"
},
{
"code" : "1597263",
"display" : "Blincyto"
},
{
"code" : "1597266",
"display" : "Blincyto Injectable Product"
},
{
"code" : "1597267",
"display" : "blinatumomab 0.035 MG Injection [Blincyto]"
},
{
"code" : "1651249",
"display" : "blinatumomab 0.035 MG"
},
{
"code" : "1651250",
"display" : "blinatumomab Injection"
},
{
"code" : "1651252",
"display" : "blinatumomab 0.035 MG [Blincyto]"
},
{
"code" : "1651253",
"display" : "blinatumomab Injection [Blincyto]"
},
{
"code" : "1660002",
"display" : "thiotepa 100 MG"
},
{
"code" : "1660003",
"display" : "thiotepa Injection"
},
{
"code" : "1660004",
"display" : "thiotepa 100 MG Injection"
},
{
"code" : "1660008",
"display" : "thiotepa 15 MG"
},
{
"code" : "1660009",
"display" : "thiotepa 15 MG Injection"
},
{
"code" : "1919206",
"display" : "thiotepa 100 MG [Tepadina]"
},
{
"code" : "1919207",
"display" : "thiotepa Injection [Tepadina]"
},
{
"code" : "1919208",
"display" : "Tepadina Injectable Product"
},
{
"code" : "1919209",
"display" : "thiotepa 100 MG Injection [Tepadina]"
},
{
"code" : "1919210",
"display" : "thiotepa 15 MG [Tepadina]"
},
{
"code" : "1919211",
"display" : "thiotepa 15 MG Injection [Tepadina]"
},
{
"code" : "1942950",
"display" : "inotuzumab ozogamicin"
},
{
"code" : "1942951",
"display" : "inotuzumab ozogamicin 0.9 MG"
},
{
"code" : "1942952",
"display" : "inotuzumab ozogamicin Injectable Product"
},
{
"code" : "1942953",
"display" : "inotuzumab ozogamicin Injection"
},
{
"code" : "1942954",
"display" : "inotuzumab ozogamicin 0.9 MG Injection"
},
{
"code" : "1942955",
"display" : "Besponsa"
},
{
"code" : "1942956",
"display" : "inotuzumab ozogamicin 0.9 MG [Besponsa]"
},
{
"code" : "1942957",
"display" : "inotuzumab ozogamicin Injection [Besponsa]"
},
{
"code" : "1942958",
"display" : "Besponsa Injectable Product"
},
{
"code" : "1942959",
"display" : "inotuzumab ozogamicin 0.9 MG Injection [Besponsa]"
},
{
"code" : "1944699",
"display" : "gemtuzumab ozogamicin 4.5 MG"
},
{
"code" : "1944700",
"display" : "gemtuzumab ozogamicin Injection"
},
{
"code" : "1944701",
"display" : "gemtuzumab ozogamicin 4.5 MG Injection"
},
{
"code" : "1944702",
"display" : "gemtuzumab ozogamicin 4.5 MG [Mylotarg]"
},
{
"code" : "1944703",
"display" : "gemtuzumab ozogamicin Injection [Mylotarg]"
},
{
"code" : "1944704",
"display" : "gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg]"
},
{
"code" : "2054068",
"display" : "mogamulizumab"
},
{
"code" : "2054077",
"display" : "mogamulizumab-kpkc"
},
{
"code" : "2054078",
"display" : "mogamulizumab-kpkc 4 MG/ML"
},
{
"code" : "2054079",
"display" : "mogamulizumab Injectable Product"
},
{
"code" : "2054080",
"display" : "mogamulizumab Injection"
},
{
"code" : "2054081",
"display" : "5 ML mogamulizumab-kpkc 4 MG/ML Injection"
},
{
"code" : "2054082",
"display" : "Poteligeo"
},
{
"code" : "2054083",
"display" : "mogamulizumab-kpkc 4 MG/ML [Poteligeo]"
},
{
"code" : "2054084",
"display" : "mogamulizumab Injection [Poteligeo]"
},
{
"code" : "2054085",
"display" : "Poteligeo Injectable Product"
},
{
"code" : "2054086",
"display" : "5 ML mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo]"
},
{
"code" : "261585",
"display" : "Mylotarg"
}
]
}
]
}
}
IG © 2020+ The Medical College of Wisconsin, Inc. and the National Marrow Donor Program
Package nmdp.fhir.cibmtr-reporting#0.1.6 based on FHIR 4.0.1. Generated 2023-05-05
Links: Table of Contents |
QA Report
HL7®, and FHIR® are the registered trademarks of Health Level Seven International
and their use of these trademarks does not constitute an endorsement by HL7.